Dorronsoro Akaitz, Fernández-Rueda Jon, Fechter Karoline, Ferrin Izaskun, Salcedo Juan Manuel, Jakobsson Emma, Trigueros César
Mesenchymal and Hematopoietic Stem Cell Department, Fundación Inbiomed, Foundation for Stem Cell Research, Paseo Mikeletegi 81, 20009 San Sebastián, Spain.
Bone Marrow Res. 2013;2013:203643. doi: 10.1155/2013/203643. Epub 2013 Sep 29.
Mesenchymal stromal cells (MSCs) are multipotent cells found in connective tissues that can differentiate into bone, cartilage, and adipose tissue. Interestingly, they can regulate immune responses in a paracrine way and allogeneic MSCs do not elicit immune response. These properties have encouraged a number of clinical trials in a broad range of regenerative therapies. Although these trials were first focused on their differentiation properties, in the last years, the immunosuppressive features have gained most of the attention. In this review, we will summarize the up-to-date knowledge about the immunosuppressive mechanisms of MSCs in vivo and in vitro and the most promising approaches in clinical investigation.
间充质基质细胞(MSCs)是存在于结缔组织中的多能细胞,可分化为骨、软骨和脂肪组织。有趣的是,它们能够以旁分泌方式调节免疫反应,而异基因MSCs不会引发免疫反应。这些特性促使人们在广泛的再生疗法中开展了多项临床试验。尽管这些试验最初关注的是其分化特性,但在过去几年中,免疫抑制特性受到了最多关注。在这篇综述中,我们将总结关于MSCs体内和体外免疫抑制机制的最新知识以及临床研究中最有前景的方法。